1 Reason to Buy Eli Lilly Stock Hand Over Fist Right Now

Eli Lilly just secured a huge win, and it's not related to the weight loss industry.Pharmaceutical powerhouse Eli Lilly (LLY 0.09%) is having a terrific 2024. Shares have gained 58% so far this year, handily outperforming both the S&P 500 and Nasdaq Composite indexes.Much of the share price appreciation can be attributed to Lilly's success in the diabetes and obesity care markets thanks to its blockbuster glucagon-like peptide-1 (GLP-1) agonists, Mounjaro and Zepbound. Moreover, Lilly made headlines back in ...